Natural history and predictors of disease severity in chronic hepatitis C
Julien Massard, Vlad Ratziu, Dominique Thabut, Joseph Moussalli, Pascal Lebray, Yves Benhamou, Thierry Poynard
Journal of Hepatology 2006, 44 (1): S19-24
16356583
Cirrhosis is the end-stage consequence of fibrosis progression in patients with chronic hepatitis C. The median time from infection to cirrhosis is 30 years, with a high inter-individual variability, which is now better understood. Several factors have been clearly shown to be associated with fibrosis progression rate: duration of infection, age, male gender, alcohol consumption, HIV co-infection and low CD4 count. Metabolic conditions such as steatosis, being overweight and diabetes are emerging as independent co-factors of fibrogenesis. The recent validation of non-invasive biomarkers should facilitate the study of fibrosis progression in large populations.
Full Text Links
Find Full Text Links for this Article
You are not logged in. Sign Up or Log In to join the discussion.